21 August 2021>: Clinical Research
Sevoflurane-Remifentanil Versus Propofol-Remifentanil Anesthesia During Noncardiac Surgery for Patients with Coronary Artery Disease – A Prospective Study Between 2016 and 2017 at a Single Center
Zhongliang Dai 1ACDE , Miao Lin 1BDE , Yali Li 1BE , Wenli Gao 1BDE , Ping Wang 1BDE , Juan Lin 1CE , Zhenzhen Wan 2AE* , Yuanxu Jiang 1CE*DOI: 10.12659/MSM.929835
Med Sci Monit 2021; 27:e929835
Table 2 Intraoperative data.
Variables | Sevoflurane (n=81) | Propofol (n=83) | P |
---|---|---|---|
Type of surgery, n (%) | |||
Major general | 14 (17.3) | 17 (20.5) | 0.342 |
Major orthopedic | 36 (44.4) | 41 (49.4) | 0.283 |
Major vascular | 31 (38.3) | 25 (30.1) | 0.211 |
Preoperative troponin elevation, n (%) | 5 (6.2) | 6 (7.2) | 0.375 |
Time of operation (minutes) | 176±34 | 182±42 | 0.186 |
Bleeding (ml) | 245±156 | 256±189 | 0.202 |
Sevoflurane inhalation concentration (%) | 2.8±0.6 | / | / |
Propofol infusion rate (kg/h) | / | 3.5±0.7 | / |
Total i.v. remifentanil (μg) | 553±78 | 612±84 | 0.791 |
BIS values | 46±13 | 44±12 | 0.826 |
BIS – bispectral index. |